Articles
27. 10. 2015 Cancer in the older population of the Czech Republic
Population ageing has become a challenge to cancer care in developed countries. Particularities of the older population must be taken into account when considering cancer treatment. However, there is a lack of consensus on guidelines for this population due to the underrepresentation of older patients in clinical trials.
15. 1. 2014 Personalised invitations of Czech citizens to cancer screening programmes
In January 2014, a project of personalised invitations for cancer screening programmes was launched in the Czech Republic. In particular, citizens are invited to participate in colorectal cancer screening (men and women), as well as breast cancer screening and cervical cancer screening (women). Personalised invitations are aimed at citizens who have not participated in cancer screening programmes in the long term, and therefore are at a higher risk of developing cancer. The project is expected to increase participation rates in Czech cancer screening programmes.
» Archive
MELANOM - data collection on patients with melanoma.
The MELANOM registry is a time-limited non-interventional post-authorization data collection on patients with melanoma. The project aims to monitor patients with modern expensive treatment of advanced disease and also monitoring of patients with adjuvant treatment. Data collection started in December 2020. The duration of the study is planned for 5 years (until the end of 2025).
start projektu: December 2020
The registry was initiated in five centres in 2020 (MOÚ, FN Olomouc, VFN, Thomayerova nemocnice, FN Hradec Králové) and will be expanded to other centres.
The creation of the registry was approved on 17th December 2019 by the committee of the Czech Oncological Society. The guarantor of the registry is Radek Lakomý, MD., Ph.D. The technical background of the project, project management, contract management, and statistical data processing is provided by the Institute of Biostatistics and Analyses, Ltd. (IBA).
The selection of patients who will be entered into the registry is the responsibility of the physician. Diagnostics and treatment procedures, prescribing of medicinal products, monitoring, and all other treatment decisions are not dependent on this project and the physician remains fully responsible for them.
The primary goal of the registry:
The primary goal is to monitor the total number of melanoma patients treated with expensive treatment in the Czech Republic. .
Secondary objectives of the project:
- Evaluation of the effectiveness of the monitored treatment and the used treatment regimens
- Analysis of patient survival concerning the observed clinical factors
- Evaluation of the safety of the monitored treatment
